KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Capital Expenditures: 2010-2015

Historic Capital Expenditures for Biocryst Pharmaceuticals (BCRX) over the last 4 years, with Dec 2015 value amounting to $4.0 million.

  • Biocryst Pharmaceuticals' Capital Expenditures rose 6124.62% to $4.0 million in Q4 2015 from the same period last year, while for Dec 2015 it was $5.1 million, marking a year-over-year increase of 4556.36%. This contributed to the annual value of $1.1 million for FY2024, which is 48.15% down from last year.
  • Latest data reveals that Biocryst Pharmaceuticals reported Capital Expenditures of $4.0 million as of Q4 2015, which was up 2,749.30% from $142,000 recorded in Q3 2015.
  • Biocryst Pharmaceuticals' Capital Expenditures' 5-year high stood at $4.0 million during Q4 2015, with a 5-year trough of -$2,000 in Q4 2012.
  • Its 3-year average for Capital Expenditures is $654,000, with a median of $103,500 in 2014.
  • Its Capital Expenditures has fluctuated over the past 5 years, first tumbled by 300.00% in 2012, then skyrocketed by 7,971.43% in 2015.
  • Biocryst Pharmaceuticals' Capital Expenditures (Quarterly) stood at $1,000 in 2011, then tumbled by 300.00% to -$2,000 in 2012, then surged by 300.00% to $4,000 in 2013, then surged by 1,525.00% to $65,000 in 2014, then soared by 6,124.62% to $4.0 million in 2015.
  • Its Capital Expenditures stands at $4.0 million for Q4 2015, versus $142,000 for Q3 2015 and $369,000 for Q2 2015.